Data / Form D filings / DIFFUSION PHARMACEUTICALS LLC
DIFFUSION PHARMACEUTICALS LLC: Form D filings
DIFFUSION PHARMACEUTICALS LLC, a pharmaceuticals company in Charlottesville, VA, filed 7 Form D notices with the SEC between 2009 and 2015. The latest, on December 22, 2015, reports $2.4 million sold of a $5 million offering to 28 investors.
Find out what DIFFUSION PHARMACEUTICALS LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2020 AVON COURT, #4, Charlottesville, VA, 22902
- Phone
- (434) 220-0718
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Virginia
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1171623
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 22, 2015 | New notice | $5,000,000 | $2,401,602 | $2,598,398 | 28 | Dec 4, 2015 | sec.gov |
| Sep 4, 2014 | New notice | $3,472,000 | $3,472,000 | $0 | 30 | Jun 30, 2014 | sec.gov |
| Jun 21, 2013 | New notice | $5,000,700 | $5,000,700 | $0 | 19 | May 30, 2013 | sec.gov |
| Oct 1, 2012 | New notice | $5,500,000 | $4,950,000 | $550,000 | 34 | Sep 14, 2012 | sec.gov |
| Apr 27, 2011 | New notice | $2,197,479 | $2,197,479 | $0 | 31 | Mar 15, 2011 | sec.gov |
| Dec 29, 2009 | New notice | $3,853,990 | $3,853,990 | $0 | 15 | Dec 15, 2009 | sec.gov |
| Aug 26, 2009 | New notice | $5,000,001 | $1,803,728 | $3,196,273 | 14 | Jul 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert W. Adams | Director | |
| David R. Jones | Executive Officer | |
| Thomas E. Byrne | Director | |
| Ben L. Shealy | Executive Officer | |
| Alan R. Levin | Director | |
| Mark T. Giles | Director | |
| John L. Gainer | Executive Officer, Director | |
| David G. Kalergis | Executive Officer, Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Dec 21, 2015 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DIFFUSION PHARMACEUTICALS LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.